Role of phlebotomy in the management of hemoglobin SC disease: Case report and review of the literature

American Journal of Hematology

Volumn 73, Issue 2, 2003, Pages 121-125

  Markham, Merry Jennifer ^b   Lottenberg, Richard ^a,b   Zumberg, Marc ^a,b,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c Division of Hematology/Oncology   (United States)

Author keywords

Hemoglobin SC; Phlebotomy; Sickle cell; Viscosity

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADULT; ALTITUDE; ARTICLE; BLOOD VESSEL OCCLUSION; BLOOD VISCOSITY; CASE REPORT; FATIGUE; HEMATOCRIT; HEMOGLOBIN SC DISEASE; HUMAN; IRON DEFICIENCY; MAGNETIC RESONANCE ANGIOGRAPHY; MALAISE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PHLEBOTOMY; PRIORITY JOURNAL; SPLEEN INFARCTION; SPLENECTOMY; VERTIGO;

ADULT; ALTITUDE; DIZZINESS; HEMATOCRIT; HEMOGLOBIN SC DISEASE; HUMANS; INFARCTION; MALE; PAIN, POSTOPERATIVE; PHLEBOTOMY; RETREATMENT; SPLEEN; SPLENECTOMY;

EID: 0037609659     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10328     Document Type: Article

References (19)

1. Rosse WF, Narla M, Petz LD, Steinberg MH. New views of sickle cell disease pathophysiology and treatment. In: Schecter GP, Berliner N, Telen MJ, editors. Hematology 2000. Washington, DC: The American Society of Hematology; 2000. p 2-17.
2. Baum KF, Dunn DT, Maude GH, Serjeant GR. The painful crisis of homozygous sickle cell disease. A study of risk factors. Arch Intern Med 1987;147:1231-1234.
3. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-16.
4. Ballas SK, Lewis CN, Noone AM, Krasnow SH, Kamarulzaman E, Burka ER. Clinical, hematological, and biochemical features of Hb SC disease. Am J Hematol. 1982;13:37-51.
5. Glader BE. Anemia. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven Press, Ltd; 1994. p 545-553.
6. Embury SH, Steinberg MH. Genetic modulators of disease. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven Press, Ltd; 1994. p 279-298.
7. Rao KRP, Patel AR, Honig GR, Vida LN, McGinnis PR. Iron deficiency and sickle cell anemia. Arch Intern Med 1983;143:1030-1032.
8. Fabry ME, Kaul DK, Raventos-Suarez C. SC erythrocytes have an abnormally high intracellular hemoglobin concentration. Pathophysiological consequences. J Clin Invest 1982;70:1315-1319.
9. Koduri PR, Agbemadzo B, Nathan S. Hemoglobin SC disease revisited: clinical study of 106 adults. Am J Hematol 2001;68:298-300.
10. Githens JH, Gross GP, Eife RF, Wallner SF. Splenic sequestration syndrome at mountain altitudes in sickle/hemoglobin C disease. J Pediatr 1977;90:203-206.
11. Wright JG, Hambleton IR, Thomas PW, Duncan ND, Venugopal S, Serjeant GR. Post-splenectomy course in homozygous sickle cell disease. J Pediatr 1999;134:304-309.
12. Rombos Y, Tassiopoulos T, Tzanetea R, Tsekoura C, Loukopoulos D. Clinical improvement of β-thal-HbS anemia by iron deficiency [letter]. Am J Hematol 1995;50:68-69.
13. Bouchair N, Manigne P, Kanfer A, Raphalen P, de Montalembert M, Hagege I, Verschuur A, Maier-Redelsperger M, Girot R. Prevention of sickle cell crises with multiple phlebotomies [French]. Arch Pediatr 2000;7:249-255.
14. Haddy TB, Castro O. Overt iron deficiency in sickle cell disease. Arch Intern Med 1982;142:1621-1624.
15. Castro O, Poillon WN, Finke H, Massac E, Kim BC. Improvement of sickle cell anemia by iron-limited erythropoiesis. Am J Hematol. 1994;47:74-81.
16. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644.
17. Steinberg MH. Management of sickle cell disease. N Engl J Med 1999;340:1021-1030.
18. Schmalzer EA, Lee JO, Brown AK, Usami S, Chien S. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion. Transfusion 1987;27:228-233.
19. Rombos Y, Tzanetea R, Kalotychou V, Konstantopoulos K, Simitzis S, Tassiopoulos T, Aessopos A, Fessas P. Amelioration of painful crises in sickle cell disease by venesections. Blood Cells Mol Dis 2002;28:283-287.